Sales of Diovan Fell 22% in 3rd Quarter of FY2013; Overall Growth of ARB Market Could Fall Short of Expectations

Domestic sales figures for individual ethical drugs in 2013 were recently announced by IMS Japan. The antiplatelet agent Plavix (clopidogrel) was the top-selling drug, while the angiotensin receptor blockers (ARBs) Blopress (candesartan) and Diovan (valsartan) retained their No. 2 and...read more